Adiponectin increases motility of human prostate cancer cells via AdipoR, p38, AMPK, and NF-κB pathways

Prostate

Volumn 69, Issue 16, 2009, Pages 1781-1789

  Tang, Chih Hsin ^a,b   Lu, Mu En ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adiponectin; Integirn; Migration; p38; Prostate cancer

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; BETA1 INTEGRIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA; VERY LATE ACTIVATION ANTIGEN 5; VIDARABINE;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; CELL LINE; CELL MOVEMENT; DRUG SYNERGISM; HUMANS; INTEGRIN ALPHA5BETA1; MALE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTATIC NEOPLASMS; PROTEIN KINASES; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 70350452142     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21029     Document Type: Article

References (32)

1. Robinson DR, Zylstra CR, Williams BO. Wnt signaling and prostate cancer. Curr Drug Targets 2008;9(7):571-580.
2. Van't Veer LJ, Weigelt B. Road map to metastasis. Nat Med 2003;9(8):999-1000.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100(1):57-70.
4. Humphries MJ. Integrin structure. Biochem Soc Trans 2000; 28(4):311-339.
5. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285(5430):1028-1032.
6. Stupack DG. The biology of integrins. Oncology (Williston Park) 2007;21(9 Suppl 3):6-12.
7. White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004;6(2):159-170. (Pubitemid 39485688)
8. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Heino J, Pyrhonen S. Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. Melanoma Res 2004; 14(1):29-37. (Pubitemid 38392411)
9. Oshita F, Kameda Y, Hamanaka N, Saito H, Yamada K, Noda K, Mitsuda A. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer. Am J Clin Oncol 2004;27(3):215-219. (Pubitemid 38737791)
10. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007;67(2):659-664. (Pubitemid 46192205)
11. Pontier SM, Muller WJ. Integrins in breast cancer dormancy. Acta Pathol Microbiol Immunol Scand Suppl 2008;116(7-8): 677-684.
12. Ritzenthaler JD, Han S, Roman J. Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling. Mol Biosyst 2008; 4(12):1160-1169.
13. King TE, Pawar SC, Majuta L, Sroka IC,WynnD, Demetriou MC, Nagle RB, Porreca F, Cress AE. The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model. PLoS ONE 2008;3(10):e3535.
14. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271(18): 10697-10703. (Pubitemid 26145805)
15. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270(45):26746-26749.
16. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003;9(15):5699-5704. (Pubitemid 37499493)
17. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer and adiponectin. Urology 2005;65(6):1168-1172.
18. Freedland SJ, Sokoll LJ, Platz EA, Mangold LA, Bruzek DJ, Mohr P, Yiu SK, Partin AW. Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J Urol 2005;174(4 Pt 1):1266-1270. (Pubitemid 41318699)
19. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116(7): 1784-1792. (Pubitemid 44033298)
20. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 1998;8(6):335-338. (Pubitemid 28159119)
21. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, NodaM, Kita S, Ueki K, Eto K,AkanumaY, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8(11):1288-1295. (Pubitemid 35373562)
22. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423(6941):762-769. (Pubitemid 36735700)
23. Huang CY, Fong YC, Lee CY, Chen MY, Tsai HC, Hsu HC, Tang CH. CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. Biochem Pharmacol 2009;77(5):794-803.
24. Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 2007;179(8):5483-5492.
25. Lai TH, Fong YC, Fu WM, Yang RS, Tang CH. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. Prostate 2008;68(12):1341-1353.
26. Trayhurn P, Wood IS. Signalling role of adipose tissue: Adipokines and inflammation in obesity. Biochem Soc Trans 2005;33(Pt 5):1078-1081. (Pubitemid 41659117)
27. Jaswal JS, Gandhi M, Finegan BA, Dyck JR, Clanachan AS. p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5′-AMP-activated protein kinase. Am J Physiol Heart Circ Physiol 2007; 292(4):H1978-H1985. (Pubitemid 46572424)
28. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB. mda-9/Syntenin regulates the metastatic phenotype in human melanomacells by activating nuclear factor-kappaB. Cancer Res 2007; 67(4):1812-1822. (Pubitemid 46383408)
29. Fong YC, Liu SC, Huang CY, Li TM, Hsu SF, Kao ST, Tsai FJ, Chen WC, Chen CY, Tang CH. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway. Lung Cancer 2009;64(3):263-270.
30. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001;276(22):18934-18940. (Pubitemid 37411214)
31. Mundy GR. Metastasis to bone: Causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2(8):584-593.
32. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 2004;29(1): 18-24. (Pubitemid 38068476)